Literature DB >> 11520080

Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.

L M Sevilla1, S S Richter, J Miller.   

Abstract

MHC class II-restricted antigen presentation requires trafficking of newly synthesized class II-invariant chain complexes from the trans-Golgi network to endosomal, peptide-loading compartments. This transport is mediated by dileucine-like motifs within the cytosolic tail of the invariant chain. Although these signals have been well characterized, the cytosolic proteins that interact with these dileucine signals and mediate Golgi sorting and endosomal transport have not been identified. Recently, an adaptor complex, AP-3, has been identified that interacts with dileucine motifs and mediates endosomal/lysosomal transport in yeast, Drosophila, and mammals. In this report, we have assessed class II-invariant chain trafficking in a strain of mice (mocha) which lacks expression of AP-3. Our studies demonstrate that the lack of AP-3 does not affect the kinetics of invariant chain degradation, the route of class II-invariant chain transport, or the rate and extent of class II-peptide binding as assessed by the generation of SDS-stable dimers. The possible role of other known or unknown adaptor complexes in class II-invariant chain transport is discussed. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520080     DOI: 10.1006/cimm.2001.1817

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments.

Authors:  Peter J McCormick; José A Martina; Juan S Bonifacino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

Review 2.  Melanosomes and MHC class II antigen-processing compartments: a tinted view of intracellular trafficking and immunity.

Authors:  Michael S Marks; Alexander C Theos; Graça Raposo
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Competition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 Nef.

Authors:  Richard S Mitchell; Rittik Chaudhuri; O Wolf Lindwasser; Kristie A Tanaka; David Lau; Rudy Murillo; Juan S Bonifacino; John C Guatelli
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

Review 4.  Presentation of phagocytosed antigens by MHC class I and II.

Authors:  Adriana R Mantegazza; Joao G Magalhaes; Sebastian Amigorena; Michael S Marks
Journal:  Traffic       Date:  2012-11-29       Impact factor: 6.215

5.  Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells.

Authors:  Adriana R Mantegazza; Susan H Guttentag; Jamel El-Benna; Miwa Sasai; Akiko Iwasaki; Hao Shen; Terri M Laufer; Michael S Marks
Journal:  Immunity       Date:  2012-05-03       Impact factor: 31.745

Review 6.  The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.

Authors:  Evelyn Gerth; Jochen Mattner
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

7.  The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.

Authors:  Dirk Elewaut; Anna P Lawton; Niranjana A Nagarajan; Emanual Maverakis; Archana Khurana; Stefan Honing; Chris A Benedict; Eli Sercarz; Oddmund Bakke; Mitchell Kronenberg; Theodore I Prigozy
Journal:  J Exp Med       Date:  2003-10-13       Impact factor: 14.307

Review 8.  Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism.

Authors:  Laura Dotta; Silvia Parolini; Alberto Prandini; Giovanna Tabellini; Maddalena Antolini; Stephen F Kingsmore; Raffaele Badolato
Journal:  Orphanet J Rare Dis       Date:  2013-10-17       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.